Literature DB >> 7015871

Immunoenzyme histochemical localization of fibrin degradation products in tissues.

J J Emeis, J Lindeman, W Nieuwenhuizen.   

Abstract

An immunoenzyme histochemical study was conducted to localize fibrin degradation products (FDPs) in rat tissues during disseminated intravascular coagulation (DIC). Serial measurements of FDP levels in serum after thrombin-induced DIC showed peak levels to be found at 30 minutes; the FDPs were rapidly cleared from the circulation (half-life about one hour). Rat tissues obtained from 10 minutes to 3 hours after the induction of DIC were studied by means of immunohistochemistry. A method was developed to differentiate FDPs from fibrin in tissue sections. This method is based on the observation that, in paraplast-embedded tissues, FDPs can be demonstrated following ethanol fixation only, and that fibrin is demonstrable after both paraformaldehyde fixation and ethanol fixation. Moreover, FDPs will react to some of the antiserums employed only, while fibrin will react to all antiserum used (antiserums against fibrin monomer, against the constituent chains of fibrinogen, and against FDP-D and -E). At 10-20 minutes after the induction of DIC, FDPs were found in kidney proximal tubule epithelial cells. These FDPs could be demonstrated using antiserum against the constituent chains of fibrinogen, but not by antiserums against FDP-D or -E. At 30-90 minutes, FDPs were found inside liver macrophages. The FDPs in liver did not react to anti-chain antiserums, though they did react to antiserums against FDP-D and -E. Since no FDPs were found in other tissues, rat FDPs are apparently cleared by kidney (earlier phase) and liver (later phase) only. In human cases of DIC, FDPs, could be demonstrated in kidney proximal tubules cells and in liver macrophages as well.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7015871      PMCID: PMC1903852     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  19 in total

1.  The roles of renal catabolism and uremia in modifying the clearance of fibrinogen and its degradative fragments D and E.

Authors:  A Iio; W E Rutherford; R D Wochner; I Spilberg; L A Sherman
Journal:  J Lab Clin Med       Date:  1976-06

2.  Effect of Trasylol on fibrin deposition and elimination in the lungs of rats with intravascular coagulation induced by thrombin or thromboplastin.

Authors:  C Diffang; T Saldeen
Journal:  Thromb Res       Date:  1974-09       Impact factor: 3.944

3.  In vivo behavior of fibrinogen fragment D in experimental renal, hepatic and reticuloendothelial dysfunction.

Authors:  O A Hayne; L A Sherman
Journal:  Am J Pathol       Date:  1973-05       Impact factor: 4.307

4.  Clearance of coagulation and fibrinolysis products by the reticuloendothelial system.

Authors:  R T Walsh; M I Barnhart
Journal:  Thromb Diath Haemorrh Suppl       Date:  1969

5.  Quantitation of fibrin deposition and elimination in organs of rats injected with labelled fibrinogen and albumin.

Authors:  C Busch; L Rammer; T Saldeen
Journal:  Thromb Diath Haemorrh       Date:  1973-02-28

6.  Quantitative monitoring of intravascular coagulation and fibrinolysis in the lungs of rats.

Authors:  D Coombey; H M Tyler
Journal:  Thromb Diath Haemorrh       Date:  1972-04-30

7.  A rapid, simple, sensitive method for measuring fibrinolytic split products in human serum.

Authors:  C Merskey; P Lalezari; A J Johnson
Journal:  Proc Soc Exp Biol Med       Date:  1969-07

Review 8.  Trends in microvascular research. The microembolism syndrome.

Authors:  T Saldeen
Journal:  Microvasc Res       Date:  1976-03       Impact factor: 3.514

9.  Rat liver macrophages will not phagocytose fibrin during disseminated intravascular coagulation.

Authors:  J J Emeis; J Lindeman
Journal:  Haemostasis       Date:  1976

10.  Studies in experimental animals on disseminated intravascular coagulation (DIC).

Authors:  F Markwardt; G Nowak; W Meerbach; K D Rüdiger
Journal:  Thromb Diath Haemorrh       Date:  1975-11-15
View more
  7 in total

1.  Macrophage metabolism of fibrin: role of fibronectin.

Authors:  J E Kaplan; T M Saba
Journal:  Surv Immunol Res       Date:  1984

2.  Histopathology of serial graft biopsies from liver transplant recipients.

Authors:  H F Eggink; N Hofstee; C H Gips; R A Krom; H J Houthoff
Journal:  Am J Pathol       Date:  1984-01       Impact factor: 4.307

3.  Adsorptive endocytosis of fibrin monomer by macrophages: evidence of a receptor for the amino terminus of the fibrin alpha chain.

Authors:  S R Gonda; J R Shainoff
Journal:  Proc Natl Acad Sci U S A       Date:  1982-08       Impact factor: 11.205

4.  Monocytes and tissue factor promote thrombosis in a murine model of oxygen deprivation.

Authors:  C A Lawson; S D Yan; S F Yan; H Liao; Y S Zhou; J Sobel; W Kisiel; D M Stern; D J Pinsky
Journal:  J Clin Invest       Date:  1997-04-01       Impact factor: 14.808

5.  Coordinated induction of plasminogen activator inhibitor-1 (PAI-1) and inhibition of plasminogen activator gene expression by hypoxia promotes pulmonary vascular fibrin deposition.

Authors:  D J Pinsky; H Liao; C A Lawson; S F Yan; J Chen; P Carmeliet; D J Loskutoff; D M Stern
Journal:  J Clin Invest       Date:  1998-09-01       Impact factor: 14.808

6.  Reduced microvascular thrombosis and improved outcome in acute murine stroke by inhibiting GP IIb/IIIa receptor-mediated platelet aggregation.

Authors:  T F Choudhri; B L Hoh; H G Zerwes; C J Prestigiacomo; S C Kim; E S Connolly; G Kottirsch; D J Pinsky
Journal:  J Clin Invest       Date:  1998-10-01       Impact factor: 14.808

7.  Ultrastructural study of the effects of tranexamic acid and urokinase on metastasis of Lewis lung carcinoma.

Authors:  N Tanaka; H Ogawa; M Kinjo; S Kohga; K Tanaka
Journal:  Br J Cancer       Date:  1982-09       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.